Processing

Please wait...

Settings

Settings

Goto Application

1. WO2021030588 - ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASE

Publication Number WO/2021/030588
Publication Date 18.02.2021
International Application No. PCT/US2020/046184
International Filing Date 13.08.2020
IPC
A61K 39/12 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
39Medicinal preparations containing antigens or antibodies
12Viral antigens
Applicants
  • COURIER THERAPEUTICS, INC. [US]/[US]
Inventors
  • KRUPNICK, Alexander, Sasha
  • LAZEAR, Eric, Reed
  • HEIN, Sarah
  • WATKINS, Daniel, Marvin
Agents
  • COX, Ryan, P.
Priority Data
62/886,00013.08.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ORTHOPOXVIRUS MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I LIKE PROTEIN (OMCP) FOR TREATMENT OF AUTOIMMUNE DISEASE
(FR) PROTÉINE DU COMPLEXE MAJEUR D'HISTOCOMPATIBILITÉ (OMCP) DE CLASSE I D'ORTHOPOXVIRUS POUR LE TRAITEMENT D'UNE MALADIE AUTO-IMMUNE
Abstract
(EN)
Compositions and methods for treatment of autoimmune and inflammatory conditions which include Orthopox Major Histocompatibility complex (MHC) class I-like protein (OMCP) or a variant thereof.
(FR)
L'invention concerne des compositions et des procédés pour le traitement d'états auto-immuns et inflammatoires qui comprennent une protéine du complexe majeur d'histocompatibilité (CMH) de classe I (OMCP) ou un variant de celle-ci.
Latest bibliographic data on file with the International Bureau